Evidera
Katarzyna Borkowska is a seasoned professional in evidence synthesis and health economics with a robust career spanning several years in prominent organizations. Currently serving as a Research Associate III at Evidera since September 2021, Katarzyna previously held multiple roles at Creativ-Ceutical, including Consultant and Senior Analyst in Health Economics and Outcomes Research from December 2016 to August 2021. Earlier experience includes positions as a Clinical Specialist and Clinical Analyst at Arcana Institute, where Katarzyna worked from April 2015 to November 2016, and a Trainee role at Arcana Institute in late 2014. Katarzyna earned a Master's Degree in Biology at Jagiellonian University from 2013 to 2015, following a Bachelor's degree in the same field from the same institution from 2010 to 2013.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.